NCT02855177View on ClinicalTrials.gov

A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 24, 2016

Primary Completion Date

April 12, 2017

Study Completion Date

April 12, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Placebo as suspension administered every 8 hours, with food

DRUG

PF-06427878

500 mg suspension administered every 8 hours, with food

Trial Locations (2)

33143

Qps-Mra, Llc, South Miami

91206

California Clinical Trials Medical Group, Glendale

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02855177 - A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects | Biotech Hunter | Biotech Hunter